EGFR and breast carcinoma: As shown in Figure 1E, Anxa2 was highly expressed in all the EGFR positive breast cancer cell lines, and strongly positive expression of Anxa2 was found in cell lines that were characterized as mesenchymal-like and highly aggressive, such as MDA-MB-231, MDA-MB-435 and MCF-7/ADR.